Inventor · disambiguated record
Guochuan Emil Tsai
Also filed as: TSAI GUOCHUAN · TSAI GUOCHUAN EMIL
40 granted patents·11 pending applications·316 citations·filing 1998–2022
97Inventor score
Files withSYNEURX INT TAIWAN CORP36GEN HOSPITAL CORP5LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT3UNIV CHINA MEDICAL3GEN HOSPTIAL CORP1
Top patents by PatentIndex Score
51 records- 0195US6420351B1Methods for treating neuropsychiatric disordersGEN HOSPTIAL CORP·Filed 2001·Granted Jul 16, 2002·77 cites·23 claims
- 0294US10149845B2Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceuticalLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2017·Granted Dec 11, 2018·5 cites·17 claims
- 0394US6228875B1Methods for treating neuropsychiatric disordersGEN HOSPITAL CORP·Filed 1999·Granted May 8, 2001·133 cites·56 claims
- 0492US10098861B1Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted Oct 16, 2018·5 cites·6 claims
- 0592US9675604B2Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceuticalLOS ANGELES BIOMEDICAL RES INST AT HARBOR-UCLA MEDICAL CENTER·Filed 2014·Granted Jun 13, 2017·7 cites·12 claims
- 0690US10485790B1Salts of cycloserine compounds and applications thereofSYNEURX INT TAIWAN CORP·Filed 2018·Granted Nov 26, 2019·2 cites·15 claims
- 0788US11278509B2Lithium salts of N-substituted glycine compounds and uses thereofSYNEURX INT TAIWAN CORP·Filed 2019·Granted Mar 22, 2022·1 cites·20 claims
- 0888US10105378B2Enrichment methods for preparing tannic acid compositionsSYNEURX INT TAIWAN CORP·Filed 2017·Granted Oct 23, 2018·6 cites·29 claims
- 0988US10039730B2Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceuticalLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2017·Granted Aug 7, 2018·2 cites·20 claims
- 1088US9877942B1Co-crystals of substituted glycine and uses thereofSYNEURX INT (TAIWAN) CORP·Filed 2017·Granted Jan 30, 2018·5 cites·11 claims
- 1188US6667297B2Methods for treating neuropsychiatric disordersGEN HOSPITAL CORP·Filed 2002·Granted Dec 23, 2003·24 cites·59 claims
- 1287US10265336B2Compositions containing tannic acids and uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted Apr 23, 2019·5 cites·17 claims
- 1386US9649304B2Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceuticalTSAI GUOCHUAN EMIL·Filed 2010·Granted May 16, 2017·10 cites·7 claims
- 1486US7704978B2Methods for treating neuropsychiatric disordersGEN HOSPITAL CORP·Filed 2005·Granted Apr 27, 2010·7 cites·21 claims
- 1585US10336679B2Polymorphic forms of sodium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted Jul 2, 2019·5 cites·12 claims
- 1685US10226442B2Lithium salts of N-substituted glycine compounds and uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted Mar 12, 2019·2 cites·22 claims
- 1785US6974821B2Methods for treating neuropsychiatric disordersGEN HOSPITAL CORP·Filed 2003·Granted Dec 13, 2005·12 cites·28 claims
- 1884US11154531B2Compounds and pharmaceutical uses thereofSYNEURX INT TAIWAN CORP·Filed 2020·Granted Oct 26, 2021·2 cites·18 claims
- 1983US10927138B2Inhibitors of D-amino acid oxidase (DAAO) and uses thereofSYNEURX INT TAIWAN CORP·Filed 2018·Granted Feb 23, 2021·3 cites·15 claims
- 2082US11369579B2Polymorphic forms of sodium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2019·Granted Jun 28, 2022·1 cites·16 claims
- 2178US2022273600A1Lithium salts of n-substituted glycine compounds and uses thereofSYNEURX INT TAIWAN CORP·Filed 2022·Application pending·0 cites
- 2274US11529342B2Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceuticalLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2018·Granted Dec 20, 2022·0 cites·19 claims
- 2374US11008277B2Co-crystals of sodium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted May 18, 2021·0 cites·19 claims
- 2474US10064833B2Compositions containing benzoate compound and tannic acid for treating central nervous system disordersSYNEURX INT TAIWAN CORP·Filed 2017·Granted Sep 4, 2018·1 cites·24 claims
- 2571US11202791B2Compositions containing tannic acids and uses thereofSYNEURX INT TAIWAN CORP·Filed 2020·Granted Dec 21, 2021·0 cites·15 claims
- 2671US10336724B2D-amino acid oxidase inhibitors and therapeutic uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted Jul 2, 2019·1 cites·11 claims
- 2770US10765651B2Co-crystals of substituted glycine and uses thereofSYNEURX INT TAIWAN CORP·Filed 2019·Granted Sep 8, 2020·0 cites·13 claims
- 2869US11779561B2Compounds and pharmaceutical uses thereofSYNEURX INT TAIWAN CORP·Filed 2022·Granted Oct 10, 2023·0 cites·12 claims
- 2968US11731928B2Co-crystals of sodium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
- 3066US11793823B2Compounds and pharmaceutical uses thereofSYNEURX INT TAIWAN CORP·Filed 2022·Granted Oct 24, 2023·0 cites·14 claims
- 3165US10328042B2Co-crystals of substituted glycine and uses thereofSYNEURX INT TAIWAN CORP·Filed 2018·Granted Jun 25, 2019·0 cites·20 claims
- 3264US11739046B2Co-crystals of lithium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2020·Granted Aug 29, 2023·0 cites·13 claims
- 3364US11382924B2Compounds and pharmaceutical uses thereofSYNEURX INT TAIWAN CORP·Filed 2021·Granted Jul 12, 2022·0 cites·24 claims
- 3463US10328041B2Co-crystals of substituted glycine and uses thereofSYNEURX INT TAIWAN CORP·Filed 2018·Granted Jun 25, 2019·0 cites·17 claims
- 3561US2019201427A1Compositions containing tannic acids and uses thereofSYNEURX INT TAIWAN CORP·Filed 2019·Application pending·0 cites
- 3659US2022304962A1Polymorphic forms of sodium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2022·Application pending·0 cites
- 3757US12178804B2Salts of cycloserine compounds and applications thereofSYNEURX INT TAIWAN CORP·Filed 2019·Granted Dec 31, 2024·0 cites·15 claims
- 3857US11291654B2Formulations of cycloserine compounds and applications thereofSYNEURX INT TAIWAN CORP·Filed 2018·Granted Apr 5, 2022·0 cites·24 claims
- 3957US10617660B2Compositions containing benzoate compound and tannic acid for treating central nervous system disordersSYNEURX INT TAIWAN CORP·Filed 2018·Granted Apr 14, 2020·0 cites·27 claims
- 4055US2022047560A1Formulations of cycloserine compounds and applications thereofSYNEURX INT TAIWAN CORP·Filed 2019·Application pending·0 cites
- 4154US2021214385A1Inhibitors of d-amino acid oxidase and uses thereofSYNEURX INT TAIWAN CORP·Filed 2019·Application pending·0 cites
- 4252US10815184B2Co-crystals of lithium benzoate and uses thereofSYNEURX INT TAIWAN CORP·Filed 2017·Granted Oct 27, 2020·0 cites·16 claims
- 4349US11753400B2D-amino acid oxidase inhibitors and therapeutic uses thereofSYNEURX INT TAIWAN CORP·Filed 2018·Granted Sep 12, 2023·0 cites·15 claims
- 4449US2023218623A1Salts of neuroceuticals and uses thereofSYNEURX INT TAIWAN CORP·Filed 2021·Application pending·0 cites
- 4549US2014273032A1Compositions and methods for diagnosis of schizophreniaUNIV CHINA MEDICAL·Filed 2014·Application pending·0 cites
- 4645US2002084230A1Methods for screening drugs to predict tardive dyskinesiaFiled 2001·Application pending·0 cites
- 4745US2014171413A1Compositions and methods for diagnosis of schizophreniaUNIV CHINA MEDICAL·Filed 2012·Application pending·0 cites
- 4844US2021162316A1Improved enrichment methods for preparing tannic acid compositionsSYNEURX INT TAIWAN CORP·Filed 2017·Application pending·0 cites
- 4939US2014288055A1Compositions and methods for diagnosis of schizophreniaUNIV CHINA MEDICAL·Filed 2014·Application pending·0 cites
- 5038US10668032B2Use of lithium benzoate for treating central nervous system disordersSYNEURX INT TAIWAN CORP·Filed 2018·Granted Jun 2, 2020·0 cites·22 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Guochuan Emil Tsai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →